Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant
In a large pediatric SOT population, overall BSI rates were significant but decreased over time. Identifying factors which contribute to BSI after SOT may direct interventions that can impact inpatient care requirements for these patients.
Authors
- Ayelet Rosenthal (ORCID: https://orcid.org/0000-0002-1143-829X)
- Mario M. Landa
- Larry K. Kociolek (ORCID: https://orcid.org/0000-0002-8756-3417)
- Caitlin Naureckas Li (ORCID: https://orcid.org/0000-0003-4737-1661)
- William J. Muller (ORCID: https://orcid.org/0000-0001-7690-0695)
- A. D. Barnes
- Mehreen Arshad (ORCID: https://orcid.org/0000-0002-7517-9274)
- Sameer Patel
- Stella Karuri (ORCID: https://orcid.org/0000-0001-7544-9345)
Institutions
- Northwestern University (US)
- Lurie Children's Hospital (US)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1111/tid.70030
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Gilead Sciences
- Children’s Hospital of Wisconsin Research Institute
- Melinta Therapeutics
- Nabriva Therapeutics
- Moderna